VITA Observation Program: Evaluation of the Effectiveness and Safety of the Drug Subetta in the Complex Therapy of Type 2 Diabetes in Ambulatory Patients
Treatment of type 2 diabetes is complicated by complex pathogenesis and chronic course. Non-compliance with the doctor's recommendations, inadequate control of glycemia, concomitant diseases -the incomplete list of reasons for long-term decompensation of the pathology. The article presents the results of the observational study of the drug Subetta in the complex therapy of patients with type 2 diabetes. The study was called VITA (All-Russian non-Interventional Observational Program for Evaluating of the Effectiveness and Safety of the Drug SubetTA). Its results confirmed the data on Subetta effect on the level of glycated hemoglobin. In particular, the addition of the drug to any hypoglycemic therapy made itpossible to reduce the indicators of glycated hemoglobin with the low risk of hypoglycemia.